mucoid exopolysaccharide p. aeruginosa immune globulin
Biologicalexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 1995 (NCT00004747)
Timeline
1990s
- Jan 1, 1995
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Pseudomonas aeruginosaImmunity, passive
Pseudomonas aeruginosa immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- mucoid exopolysaccharide p. aeruginosa immune globulin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00004747 | Phase 2 | Jul 1, 1995 | National Center for Research Resources (NCRR), Vanderbilt University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Center for Research Resources (NCRR) | Government | 1 | 1 | 1 | 1995 |
| Vanderbilt University | Academic/Hospital | 1 | 0 | 1 | 1995 |
2 organizations
Page 1 / 1